In MSS CRC, myeloid cells that sense bacteria through toll-like receptors induce the secretion of calcineurin and IL-6, resulting in the expression of the co-inhibitory molecules B7H3 and B7H4 by tumor cells, thereby suppressing the anti-tumour response of CD8+T cells [95, 96]. Here, CD276 is linked to neoplasm.